Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 1
1991 3
1992 3
1993 5
1994 9
1995 8
1996 6
1997 4
2001 2
2003 1
2004 1
2005 2
2006 1
2007 2
2008 1
2009 3
2013 1
2014 1
2016 5
2017 4
2018 2
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.
Ecke TH, Meisl CJ, Schlomm T Prof, Rabien A, Labonté F, Rong D, Hofbauer S, Friedersdorff F Prof, Sommerfeldt L, Gagel N, Gössl A, Barski D, Otto T Prof, Grunewald CM, Niegisch G Prof, Hennig MJP, Kramer MW Prof, Koch S Prof, Roggisch J, Hallmann S, Weiß S, Waldner M, Graff J, Veltrup E, Linden F, Hake R, Eidt S, Wirtz RM. Ecke TH, et al. Among authors: eidt s. Urol Oncol. 2023 Dec;41(12):484.e17-484.e26. doi: 10.1016/j.urolonc.2023.06.013. Epub 2023 Jul 4. Urol Oncol. 2023. PMID: 37407421
[Microscopic colitis].
Pohl C, Eidt S, Kruis W. Pohl C, et al. Among authors: eidt s. Dtsch Med Wochenschr. 2005 Aug 26;130(34-35):1962-7. doi: 10.1055/s-2005-872611. Dtsch Med Wochenschr. 2005. PMID: 16123901 Review. German. No abstract available.
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F, Hake R, Eidt S, Roggisch J, Heidenreich A, Rieger C, Kastner L, Hallmann S, Koch S, Wirtz RM. Ecke TH, et al. Among authors: eidt s. Int J Mol Sci. 2022 Jul 18;23(14):7898. doi: 10.3390/ijms23147898. Int J Mol Sci. 2022. PMID: 35887247 Free PMC article.
CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses.
Wennhold K, Thelen M, Lehmann J, Schran S, Preugszat E, Garcia-Marquez M, Lechner A, Shimabukuro-Vornhagen A, Ercanoglu MS, Klein F, Thangarajah F, Eidt S, Löser H, Bruns C, Quaas A, von Bergwelt-Baildon M, Schlößer HA. Wennhold K, et al. Among authors: eidt s. Cancer Immunol Res. 2021 Sep;9(9):1098-1108. doi: 10.1158/2326-6066.CIR-20-0949. Epub 2021 Jun 21. Cancer Immunol Res. 2021. PMID: 34155067
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS. Shimabukuro-Vornhagen A, et al. Among authors: eidt s. Oncotarget. 2014 Jul 15;5(13):4651-64. doi: 10.18632/oncotarget.1701. Oncotarget. 2014. PMID: 25026291 Free PMC article.
72 results